News

A New Blood Biomarker Predicts the Progression of Alzheimer’s Disease Even in Its Earliest Stages

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression o...

Dr. Oriol Dols-Icardo Leads a Scientific Commentary on Genetic Advances in Frontotemporal Dementia

The prestigious journal Trends in Neurosciences recently published a scientific commentary authored by Dr. Oriol Dols-Icardo, a researcher with the Neurobiology of Dementias group at the Sant Pau Rese...

The Technology Transfer and Innovation Unit at IR Sant Pau Earns International ISO 56001 Certification in Innovation Management

The Technology Transfer and Innovation Unit (UTI) at the Sant Pau Research Institute (IR Sant Pau) has obtained ISO 56001 certification, an international standard that sets out the requirements for im...

The CADASIMUS Project Receives Seed Funding from the RICORS-ICTUS Network

The Sant Pau Research Institute (IR Sant Pau) is actively participating in the CADASIMUS project, a collaborative initiative recently selected in the “Dr. Miguel Blanco” seed funding call of the R...

The Use of Biomarkers in Cognitively Healthy Adults Should Be Cautious and Based on Inclusive Risk Models

Early detection of Alzheimer’s disease has undergone a shift recently with the incorporation of biomarkers that allow for the identification of brain changes even before the first symptoms appear. H...